D002626OccupationsProceduresH01.158.703.007H01.181.466Chemistry, Pharmaceuticalprns:hasAuthorListauthor listprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:meshTreeNumberMeSH tree numberprns:minWeightminimum weightprns:numberOfConnectionsnumber of connectionsprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierInformation Resourcevivo:subjectAreaForsubject area forrdf:predicatepredicaterdf:typetyperdfs:labellabelConcept12616667Abdel-Rahman SM, Johnson FK, Gauthier-Dubois G, Weston IE, Kearns GLJournal of clinical pharmacologyAbdel-Rahman SM, Johnson FK, Gauthier-Dubois G, Weston IE, Kearns GL. The bioequivalence of nizatidine (Axid) in two extemporaneously and one commercially prepared oral liquid formulations compared with capsule. J Clin Pharmacol. 2003 Feb; 43(2):148-53.J Clin Pharmacol2003-02-01T00:00:002003The bioequivalence of nizatidine (Axid) in two extemporaneously and one commercially prepared oral liquid formulations compared with capsule.23149009Abdel-Rahman SM, Amidon GL, Kaul A, Lukacova V, Vinks AA, Knipp GTClinical therapeuticsAbdel-Rahman SM, Amidon GL, Kaul A, Lukacova V, Vinks AA, Knipp GT. Summary of the National Institute of Child Health and Human Development-best pharmaceuticals for Children Act Pediatric Formulation Initiatives Workshop-Pediatric Biopharmaceutics Classification System Working Group. Clin Ther. 2012 Nov; 34(11):S11-24.Clin Ther2012-11-01T00:00:002012Summary of the National Institute of Child Health and Human Development-best pharmaceuticals for Children Act Pediatric Formulation Initiatives Workshop-Pediatric Biopharmaceutics Classification System Working Group.0.113480.05773372subject area for